Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brouwer

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
The American Journal of Gastroenterology|July 23, 2025
A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population SettingLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
JHEP Reports : Innovation in Hepatology|September 24, 2021
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis BLaurens A van Kleef, Hannah S J Choi, Willem P Brouwer, et al.
European Journal of Endocrinology|March 5, 2005
Thyroid and adrenal axis in major depression: a controlled study in outpatientsJantien P Brouwer, Bente C Appelhof, Witte J G Hoogendijk, et al.
Journal of Viral Hepatitis|September 13, 2021
Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infectionHannah S J Choi, Milan J Sonneveld, Mina S Farag, et al.
Anti-Cancer Drugs|March 24, 2022
The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancerThomas P Brouwer, Sabina Y van der Zanden, Manon van der Ploeg, et al.
European Journal of Endocrinology|May 27, 2006
Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depressionJantien P Brouwer, Bente C Appelhof, Robin P Peeters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 7, 2014
The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patientsWillem P Brouwer, Adriaan J van der Meer, Andre Boonstra, et al.
Journal of Viral Hepatitis|September 26, 2015
Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patientsW P Brouwer, M J Sonneveld, Q Xie, et al.
Hepatology (Baltimore, Md.)|January 22, 2017
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis BKhaled Thabet, Henry Lik Yuen Chan, Salvatore Petta, et al.
Gastro Hep Advances|April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult PopulationLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
The American Journal of Gastroenterology|July 23, 2025
A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population SettingLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
JHEP Reports : Innovation in Hepatology|September 24, 2021
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis BLaurens A van Kleef, Hannah S J Choi, Willem P Brouwer, et al.
European Journal of Endocrinology|March 5, 2005
Thyroid and adrenal axis in major depression: a controlled study in outpatientsJantien P Brouwer, Bente C Appelhof, Witte J G Hoogendijk, et al.
Journal of Viral Hepatitis|September 13, 2021
Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infectionHannah S J Choi, Milan J Sonneveld, Mina S Farag, et al.
Anti-Cancer Drugs|March 24, 2022
The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancerThomas P Brouwer, Sabina Y van der Zanden, Manon van der Ploeg, et al.
European Journal of Endocrinology|May 27, 2006
Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depressionJantien P Brouwer, Bente C Appelhof, Robin P Peeters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 7, 2014
The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patientsWillem P Brouwer, Adriaan J van der Meer, Andre Boonstra, et al.
Journal of Viral Hepatitis|September 26, 2015
Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patientsW P Brouwer, M J Sonneveld, Q Xie, et al.
Hepatology (Baltimore, Md.)|January 22, 2017
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis BKhaled Thabet, Henry Lik Yuen Chan, Salvatore Petta, et al.
Gastro Hep Advances|April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult PopulationLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Pageof 13